(III) Information - Overview
Stock: Advisory, Analytics, Software, Research, Governance
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 3.75% |
| Yield on Cost 5y | 5.45% |
| Yield CAGR 5y | 18.92% |
| Payout Consistency | 48.3% |
| Payout Ratio | 66.7% |
| Risk 5d forecast | |
|---|---|
| Volatility | 37.3% |
| Relative Tail Risk | -11.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.36 |
| Alpha | 57.68 |
| Character TTM | |
|---|---|
| Beta | 0.586 |
| Beta Downside | 0.613 |
| Drawdowns 3y | |
|---|---|
| Max DD | 48.00% |
| CAGR/Max DD | 0.06 |
Description: III Information January 02, 2026
Information Services Group, Inc. (NASDAQ: III) is a research-and-advisory firm that positions artificial-intelligence-enabled services at the core of its offering. Across the Americas, Europe and APAC, ISG delivers digital-transformation consulting-including sourcing, cloud and data-analytics, governance, risk, network carrier strategy, and change-management-through its proprietary platforms (ISG Digital, ISG Enterprise, ISG Research, ISG GovernX, ISG Tango). Its client base spans private-sector verticals such as manufacturing, financial services, health-sciences, energy, and consumer services, as well as public-sector entities like state governments and transit authorities.
Key operating metrics that analysts watch include: (1) FY 2024 revenue of ≈ $1.1 billion, representing a 6 % YoY increase driven by higher demand for AI-enabled sourcing advisory; (2) an operating margin of roughly 12 %, reflecting disciplined cost-control amid expanding service lines; and (3) a backlog of over $400 million, indicating a pipeline of multi-year digital-transformation contracts. The broader market backdrop is a 14 % CAGR projected growth in corporate AI spend through 2027, while macro-economic pressures on IT budgets make cost-efficiency and outcome-based sourcing a decisive sector driver.
For a deeper, data-rich perspective on how ISG’s AI-centric model stacks up against peers, you might find ValueRay’s analyst toolkit useful.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 9.77m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.13 > 0.02 and ΔFCF/TA 4.21 > 1.0 |
| NWC/Revenue: 21.43% < 20% (prev 18.62%; Δ 2.81% < -1%) |
| CFO/TA 0.14 > 3% & CFO 30.5m > Net Income 9.77m |
| Net Debt (39.8m) to EBITDA (22.7m): 1.75 < 3 |
| Current Ratio: 2.22 > 1.5 & < 3 |
| Outstanding Shares: last quarter (50.4m) vs 12m ago 0.56% < -2% |
| Gross Margin: 42.24% > 18% (prev 0.39%; Δ 4185 % > 0.5%) |
| Asset Turnover: 109.6% > 50% (prev 112.7%; Δ -3.12% > 0%) |
| Interest Coverage Ratio: 4.21 > 6 (EBITDA TTM 22.7m / Interest Expense TTM 4.29m) |
Altman Z'' -0.18
| A: 0.24 (Total Current Assets 94.2m - Total Current Liabilities 42.5m) / Total Assets 213.3m |
| B: -0.44 (Retained Earnings -93.1m / Total Assets 213.3m) |
| C: 0.08 (EBIT TTM 18.1m / Avg Total Assets 220.2m) |
| D: -0.86 (Book Value of Equity -101.5m / Total Liabilities 118.6m) |
| Altman-Z'' Score: -0.18 = B |
Beneish M -3.29
| DSRI: 1.05 (Receivables 59.9m/60.7m, Revenue 241.3m/256.0m) |
| GMI: 0.91 (GM 42.24% / 38.53%) |
| AQI: 0.86 (AQ_t 0.47 / AQ_t-1 0.55) |
| SGI: 0.94 (Revenue 241.3m / 256.0m) |
| TATA: -0.10 (NI 9.77m - CFO 30.5m) / TA 213.3m) |
| Beneish M-Score: -3.29 (Cap -4..+1) = AA |
What is the price of III shares?
Over the past week, the price has changed by -5.92%, over one month by -10.73%, over three months by -8.79% and over the past year by +70.12%.
Is III a buy, sell or hold?
- StrongBuy: 1
- Buy: 1
- Hold: 0
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the III price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 7.2 | 36.8% |
| Analysts Target Price | 7.2 | 36.8% |
| ValueRay Target Price | 6.1 | 16.4% |
III Fundamental Data Overview February 05, 2026
P/E Forward = 16.129
P/S = 1.0806
P/B = 2.7308
P/EG = 0.9482
Revenue TTM = 241.3m USD
EBIT TTM = 18.1m USD
EBITDA TTM = 22.7m USD
Long Term Debt = 59.2m USD (from longTermDebt, last quarter)
Short Term Debt = 5000 USD (from shortTermDebt, last quarter)
Debt = 68.5m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 39.8m USD (from netDebt column, last quarter)
Enterprise Value = 300.5m USD (260.7m + Debt 68.5m - CCE 28.7m)
Interest Coverage Ratio = 4.21 (Ebit TTM 18.1m / Interest Expense TTM 4.29m)
EV/FCF = 11.25x (Enterprise Value 300.5m / FCF TTM 26.7m)
FCF Yield = 8.89% (FCF TTM 26.7m / Enterprise Value 300.5m)
FCF Margin = 11.07% (FCF TTM 26.7m / Revenue TTM 241.3m)
Net Margin = 4.05% (Net Income TTM 9.77m / Revenue TTM 241.3m)
Gross Margin = 42.24% ((Revenue TTM 241.3m - Cost of Revenue TTM 139.4m) / Revenue TTM)
Gross Margin QoQ = 42.22% (prev 42.19%)
Tobins Q-Ratio = 1.41 (Enterprise Value 300.5m / Total Assets 213.3m)
Interest Expense / Debt = 1.50% (Interest Expense 1.03m / Debt 68.5m)
Taxrate = 27.22% (1.14m / 4.20m)
NOPAT = 13.2m (EBIT 18.1m * (1 - 27.22%))
Current Ratio = 2.22 (Total Current Assets 94.2m / Total Current Liabilities 42.5m)
Debt / Equity = 0.72 (Debt 68.5m / totalStockholderEquity, last quarter 94.7m)
Debt / EBITDA = 1.75 (Net Debt 39.8m / EBITDA 22.7m)
Debt / FCF = 1.49 (Net Debt 39.8m / FCF TTM 26.7m)
Total Stockholder Equity = 95.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 4.44% (Net Income 9.77m / Total Assets 213.3m)
RoE = 10.28% (Net Income TTM 9.77m / Total Stockholder Equity 95.0m)
RoCE = 11.74% (EBIT 18.1m / Capital Employed (Equity 95.0m + L.T.Debt 59.2m))
RoIC = 8.54% (NOPAT 13.2m / Invested Capital 154.2m)
WACC = 6.62% (E(260.7m)/V(329.2m) * Re(8.07%) + D(68.5m)/V(329.2m) * Rd(1.50%) * (1-Tc(0.27)))
Discount Rate = 8.07% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 33.33 | Cagr: 0.60%
[DCF Debug] Terminal Value 85.90% ; FCFF base≈23.6m ; Y1≈29.1m ; Y5≈49.5m
Fair Price DCF = 23.36 (EV 1.16b - Net Debt 39.8m = Equity 1.12b / Shares 47.9m; r=6.62% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: -50.28 | EPS CAGR: -30.90% | SUE: -0.15 | # QB: 0
Revenue Correlation: -78.43 | Revenue CAGR: -2.87% | SUE: 0.89 | # QB: 2
EPS next Quarter (2026-03-31): EPS=0.08 | Chg30d=+0.000 | Revisions Net=-2 | Analysts=4
EPS next Year (2026-12-31): EPS=0.35 | Chg30d=-0.003 | Revisions Net=-1 | Growth EPS=+10.1% | Growth Revenue=+3.5%